HOME >> BIOLOGY >> NEWS
Toxic molecule may cause most common type of muscular dystrophy

Doctors at the University of Virginia Health System have shown for the first time that getting rid of poisonous RNA (ribonucleic acid) in muscle cells can reverse myotonic dystrophy, the most common type of muscular dystrophy in adults.

About 40,000 people in the United States have myotonic muscular dystrophy (MMD). The disease can cause a slow, progressive wasting of the muscles, irregular heartbeat, cataracts and insulin resistance. Many people don't know they have MMD until their teens or twenties.

To prove the theory that toxic RNA is involved in myotonic muscular dystrophy, a research team led by Dr. Mani Mahadevan, a UVa pathologist, duplicated the disease in mice. "We showed in our mouse model that when you make this poisonous RNA the mice get various aspects of myotonic dystrophy," Mahadevan said. "Then, when you take away the toxic RNA, the mice get back to normal."

Mahadevan hopes the research might lead to new therapies for MMD in the next few years. "If we develop a therapy to silence the expression of the toxic RNA molecule, that would be a viable approach to treat people with myotonic muscular dystrophy," he said. Mahadevan's research in published in the September 2006 issue of Nature Genetics and can be found online at: http://www.nature.com/ng/index.html

Making RNA is the second step in the conversion of DNA into proteins that determine the function of the body's cells. Myotonic muscular dystrophy is the first example of a disease caused by toxic RNA.

In 1992, Mahadevan discovered the gene mutation that causes myotonic muscular dystrophy (type 1) as part of a research group in Canada. The mutation is an increased number of CTG repeats in a gene called DMPK. Everyone with myotonic muscular dystrophy has that mutation on chromosome 19, which is now part of a genetic, diagnostic test for myotonic dystrophy.

In their latest r
'"/>

Contact: Megan Rowe
meganrowe@virginia.edu
434-924-5679
University of Virginia Health System
24-Aug-2006


Page: 1 2

Related biology news :

1. Toxic milk
2. USGS at Society of Environmental Toxicology and Chemistry
3. Penn receives $4 million to establish a Center of Excellence in Environmental Toxicology
4. Toxic waves
5. Toxicology-on-a-chip tool readies for market
6. Researcher: Toxic flood lifts lid on common urban pollution problem
7. Toxic flame retardant accumulates in dolphins
8. Small molecules may explain psoriasis
9. Allergy molecule identified
10. Frog molecule could provide drug treatment for brain tumors
11. TU Delft tracks the influence of a cancer inhibitor on a single DNA molecule

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... January 24, 2020 , ... The Rockies ... capital resources to support early-stage bioscience companies in the state. , ... to find the funding they need to innovate and grow. This program ...
(Date:1/23/2020)... ATLANTA (PRWEB) , ... January 23, 2020 , ... ... to manufacture lifesaving mature red blood cells from stem cells. The red ... red blood cells, under strictly controlled conditions, for transfusion therapy and replaces the ...
(Date:1/22/2020)... ... ... Lifecycle Biotechnologies announces the new line of high purity powder chemicals filled into multiuse ... requirements and accurately weighed to 0.001 of a gram. The new line of powder chemicals ... , Carbohydrates , Phosphates , Chelators , ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader ... and controllers ideal for BioPharm OEMS. Sierra also announces RedyCompactâ„¢ ... thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable ...
(Date:1/22/2020)... ... January 20, 2020 , ... Brilliant, maker of the award-winning ... independent electronics distributor in the US, to make it easy for homebuilders, multifamily ... smart home products from a single fulfillment partner. Ranging from entry-level systems for ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies ... Genome editing. The partners have agreed to co-develop and market a portfolio of ... and pre-clinical programs. Over the longer-term, the parties aim to develop a COBO ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... the vendor qualification process, a critical element of clinical trial set up and ... the vendor qualification process creates delays in initiation in 7% of clinical trials ...
Breaking Biology Technology:
Cached News: